[研究报告] 宫颈癌治疗市场预计将从 2022 年的 94.3394 亿美元增长到 2030 年的 140.7408 亿美元;预计 2022 年至 2030 年市场复合年增长率为 5.13%。
市场洞察和分析师观点:
宫颈癌治疗市场预测 可以帮助利益相关者规划他们的增长战略。
宫颈癌是指发生在宫颈细胞中的癌症,宫颈是子宫下部,与阴道相连。90% 的宫颈恶性肿瘤是由 HPV 感染引起的,可通过涂片筛查诊断。宫颈癌患病率的上升和 HPV 感染率的上升是推动宫颈癌治疗市场增长的关键因素。然而,对诊断和治疗方法缺乏认识阻碍了市场的增长。宫颈癌治疗市场趋势包括宫颈癌诊断和药物研发的增加。
增长动力和挑战:
宫颈癌患病率上升推动宫颈癌治疗市场发展
在全球范围内,癌症正在成为导致死亡的主要原因之一。根据世界卫生组织 (WHO) 的数据,癌症是 183 个国家/地区 70 岁以下人群的首要死亡原因,而在其他 123 个国家/地区,癌症是 2019 年全球第四大死亡原因。此外,根据世界卫生组织 2021 年 3 月发布的数据,2020 年有近 1000 万人死于各种形式的癌症。所考虑的市场已显示出显着的扩张,这可能与全球女性宫颈癌发病率上升有关。根据世界卫生组织 (WHO) 的数据,宫颈癌每年导致超过 270,000 名女性死亡。由于疾病发现较晚,较贫穷国家的宫颈癌死亡率很高。
宫颈癌发病率的不断上升给世界各地的医疗保健系统带来了负担。根据国际癌症研究机构 (IARC) 的数据,全球新发癌症病例预计将达到约 2750 万例,到 2040 年,该疾病可能会导致约 1.63 亿人死亡。生活方式的改变、吸烟、减少体力活动以及不确定的健康和气候条件等因素预计会在未来几年增加全球癌症的负担。因此,控制和预防全球日益增加的癌症数量至关重要。
民众、医疗服务提供者和政策制定者对宫颈癌缺乏认识;无法获得高质量的医疗服务和宫颈筛查项目;以及缺乏有效的转诊系统,都是导致宫颈癌高发病率和死亡率的因素。由于细胞学筛查的机会增加以及早期宫颈病变的快速治疗,工业化国家的宫颈癌发病率和死亡率已经降低。在中低收入国家 (LMIC) 中,实施以人群为基础的宫颈筛查并提高其接受度对于降低宫颈癌死亡率至关重要。提高对风险因素的认识,例如年轻时首次性交和有多位男性性伴侣;与 HPV 8、9 和 10 型相关的高风险;年轻时第一次足月妊娠;长期使用口服避孕药;以及 HIV 感染,可能有助于提高筛查项目的参与度。更好地了解宫颈癌症状,如经间期阴道出血、绝经后阴道出血、性交后阴道出血、恶臭阴道分泌物和下腹部疼痛,可能有助于女性尽早寻求帮助。因此,民众对宫颈癌缺乏认识阻碍了宫颈癌治疗市场的增长。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
报告细分和范围:
节段分析:
根据类型,市场细分为鳞状细胞癌、腺鳞状细胞癌和腺癌。鳞状细胞癌部分在 2022 年占据了较大的宫颈癌治疗市场份额,预计在 2022-2030 年期间将实现更高的复合年增长率。根据产品,市场分为手术、放射治疗、化疗、免疫治疗和治疗性疫苗。预计到 2030 年,手术部分将占据相当大的份额。就最终用户而言,市场分为医院、家庭护理、癌症中心和其他。就最终用户而言,医院部分在 2022 年占据了最大的宫颈癌治疗市场份额。
区域分析:
在地理方面,宫颈癌治疗市场报告的范围涵盖北美、欧洲、亚太地区、中东和非洲以及南美和中美洲。2022 年,北美占据了最大的宫颈癌治疗市场份额。在北美,美国占有相当大的份额。持续进行的研发活动、政府和其他公共和私人组织的财政援助、IT 和制药公司之间的合作以及神经系统疾病发病率的上升主要推动了该国市场的增长。此外,预计政府为改进检测程序而采取的战略举措将在预测期内使市场受益。越来越多地采用与罕见疾病有关的法规很可能为市场扩张提供机会。例如,美国癌症协会 (ACS) 于 2020 年 9 月修订了宫颈癌筛查标准。
宫颈癌治疗市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响宫颈癌治疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的宫颈癌治疗市场细分和地理位置。
- 获取宫颈癌治疗市场的区域特定数据
宫颈癌治疗市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 94.3394亿美元 |
2030 年市场规模 | 140.7408 亿美元 |
全球复合年增长率(2022 - 2030 年) | 5.13% |
史料 | 2020-2022 |
预测期 | 2022-2030 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
宫颈癌治疗市场参与者密度:了解其对业务动态的影响
宫颈癌治疗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在宫颈癌治疗市场运营的主要公司有:
- F. 霍夫曼-罗氏有限公司
- 默克夏普
- 多美公司
- 葛兰素史克公司
- 基因泰克公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解宫颈癌治疗市场的主要参与者概况
行业发展和未来机遇:
宫颈癌治疗市场分析是通过识别和评估市场中的关键参与者来进行的。以下列出了主要市场参与者采取的一些举措:
- 2024 年 1 月,辉瑞公司和 Genmab A/S 宣布,美国食品药品监督管理局 (FDA) 接受了补充生物制品许可申请 (sBLA),以转换 TIVDAK (tisotumab vedotin-tftv) 的批准,用于治疗复发性或转移性宫颈癌患者,这些患者在接受一线治疗期间或之后病情出现进展。该申请已获得《处方药使用者付费法案》(PDUFA) 目标日期为 2024 年 5 月 9 日,并被授予优先审查资格。
- 2023年9月,广州格莱雅生物科技(GloriaBio)宣布,全人源抗PD-1单克隆抗体Zimberelimab注射液(YuTuo,GLS-010)已获得中国国家药品监督管理局(NMPA)上市许可。该注射液可作为单药治疗复发性或转移性宫颈癌(R/M CC)患者。Zimberelimab是全球第三个获批用于治疗宫颈癌的免疫检查点抑制剂(ICI)抗体,也是中国首个也是唯一一个获批的抗体。
竞争格局和重点公司:
F. Hoffmann-La Roche Ltd、默克夏普、Dohme Corp.、葛兰素史克公司、基因泰克公司、安进公司、Advaxis Inc.、Biocon、Allergan Inc.、辉瑞公司和阿斯利康是宫颈癌治疗市场报告中介绍的几家主要公司。这些公司专注于扩大其产品范围,以满足全球日益增长的消费者需求。它们的全球业务使它们能够为众多客户提供服务,从而扩大其市场占有率。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The cervical cancer treatment market is expected to be valued at US$ 14,074.08 million in 2030.
Based on type, the cervical cancer treatment market is segmented into squamous cell carcinoma, adenosquamous carcinoma, and adenocarcinoma. The squamous cell carcinoma segment held a larger cervical cancer treatment market share in 2022 and is anticipated to register a higher CAGR during 2022–2030.
The cervical cancer treatment market was valued at US$ 9,433.94 million in 2022.
Based on product, the market is divided into surgery radiation therapy, chemotherapy, immunotherapy, and therapeutic vaccines..
Cervical cancer refers to the cancer that occurs in the cells of the cervix, i.e., the lower part of the uterus that connects to the vagina. In 90% of the cases, cervical malignancies occur due to the HPV infection and are diagnosed through smear screening.
The increasing prevalence of cervical cancer and the rise in HPV infections are the key factors driving the cervical cancer treatment market growth. However, the lack of awareness about the diagnosis and treatment methods hampers the growth of the market. Cervical cancer treatment market trends include the increasing R&D for cervical cancer diagnosis and drugs
The cervical cancer treatment market has major market players, including F. Hoffmann-La Roche Ltd, Merck Sharp, Dohme Corp., GlaxoSmithKline plc., Genentech Inc., Amgen Inc., Advaxis Inc., Biocon, Allergan Inc., Pfizer Inc., and AstraZeneca.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Cervical Cancer Treatment Market
- F. Hoffmann-La Roche Ltd
- Merck Sharp
- Dohme Corp.
- GlaxoSmithKline plc.
- Genentech, Inc.
- Amgen Inc.
- Advaxis, Inc.
- Biocon
- Allergan, Inc
- Pfizer Inc
- AstraZeneca
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.